Travelers Companies
TRV NYSE Property & Casualty Insurance Financials FY2016βFY2025
Travelers Companies' revenue rose 5.2% to $48.8 billion in fiscal 2025. Its net margin was 12.9%, up from 10.8% a year earlier. It paid out $4.0 billion in dividends and buybacks. The diluted share count fell 1.5%.
About these figures. Debt is the total of Travelers' long-term and short-term debt, including its commercial paper, as its filings tag it. Travelers's cash flow statement doesn't show its spending on property and equipment as a line of its own, so capital spending and free cash flow are left blank.
What Travelers Companies does
No business description yet.
- Legal name
- Travelers Companies, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000086312-26-000065
0000086312
Revenue and margins
Travelers Companies had $48.8B of revenue in fiscal 2025, up 5.2% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 11.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Travelers Companies returned $4.0B to shareholders in fiscal 2025. The diluted share count fell 1.5%.
Value Travelers Companies yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$2.7B and divides by 227.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 10.5x Β· peers 10.1x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Travelers Companies can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $4.6B | $4.3B | $5.8B | $5.5B | $6.6B |
| Debt incl. finance leases | $7.3B | $7.3B | $8.0B | $8.0B | $9.3B |
| Net debt / EBITDA | 0.5x | 0.7x | 0.5x | 0.4x | 0.3x |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 14.1x | 10.6x | 10.0x | 16.8x | 19.3x |
| Total assets | $120.5B | $115.7B | $126.0B | $133.2B | $143.7B |
| Total liabilities | $91.6B | $94.2B | $101.1B | $105.3B | $110.8B |
| Shareholders' equity | $28.9B | $21.6B | $24.9B | $27.9B | $32.9B |
| Net debt (β = net cash) | $2.7B | $3.0B | $2.2B | $2.6B | $2.7B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$35.5M
9 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Maria OlivoEVP, ERM & Chief Risk Officer | Sold | 15,100 | $398.44 | $6.0M | Form 4 |
| Oct 20, 2026 | Michael Frederick KleinEVP & President, Personal Ins. | Sold | 7,500 | $392.79 | $2.9M | Form 4 |
| Aug 28, 2026 | Maria OlivoEVP, ERM & Chief Risk Officer | Sold | 6,000 | $369.86 | $2.2M | Form 4 |
| Jul 24, 2026 | Daniel Tei-Hwa YinEVP & Co-Chief Invest. Officer | Sold | 7,153 | $387.00 | $2.8M | Form 4 |
| Jul 24, 2026 | Diane KurtzmanEVP & Chief HR Officer | Sold | 4,164 | $386.71 | $1.6M | Form 4 |
| Jul 22, 2026 | Andy F BessetteEVP and Chief Admin Officer | Sold | 3,000 | $368.12 | $1.1M | Form 4 |
| Jul 22, 2026 | David Donnay RowlandEVP & Co-Chief Invest. Officer | Sold | 5,000 | $371.69 | $1.9M | Form 4 |
| Jul 22, 2026 | Paul E. MunsonSVP & Corp. Controller | Sold | 1,525 | $369.91 | $0.6M | Form 4 |
| Jul 21, 2026 | Daniel S. FreyEVP & Chief Financial Officer | Sold | 14,037 | $368.24 | $5.2M | Form 4 |
| Jul 21, 2026 | Michael Frederick KleinEVP & President, Personal Ins. | Sold | 6,000 | $366.09 | $2.2M | Form 4 |
| Jul 21, 2026 | Mojgan M LefebvreEVP & Chief Tech & Ops Officer | Sold | 16,313 | $368.38 | $6.0M | Form 4 |
| May 26, 2026 | Michael Frederick KleinEVP & President, Personal Ins. | Sold | 10,000 | $307.65 | $3.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β3.9% | β3.1% | β3.1% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Travelers Companies TRV | $83.9B | 5.2% | β | β | 20.1% | 10.5x | β | |
| Chubb CB | $140.1B | 6.5% | β | β | 13.6% | 12.6x | β | Compare β |
| Allstate ALL | $65.6B | 5.6% | β | 14.6% | 37.3% | 5.1x | β | Compare β |
| Hartford HIG | $37.8B | 6.9% | β | 20.3% | 22.6% | 8.8x | β | Compare β |
| Progressive PGR | $133.2B | 16.3% | β | 19.6% | 39.2% | 11.4x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $27.6B | $28.9B | $30.3B | $31.6B | $32.0B | $34.8B | $36.9B | $41.4B | $46.4B | $48.8B |
| Interest expense | $363M | $369M | $352M | $344M | $339M | $340M | $351M | $376M | $392M | $425M |
| Pretax income | $4.1B | $2.7B | $3.0B | $3.1B | $3.2B | $4.5B | $3.4B | $3.4B | $6.2B | $7.8B |
| Income tax | $1.0B | $674M | $438M | $516M | $540M | $796M | $512M | $380M | $1.2B | $1.5B |
| Net income | $3.0B | $2.1B | $2.5B | $2.6B | $2.7B | $3.7B | $2.8B | $3.0B | $5.0B | $6.3B |
| Diluted EPS | $10.28 | $7.33 | $9.28 | $9.92 | $10.52 | $14.49 | $11.77 | $12.79 | $21.47 | $27.43 |
| Diluted shares | 0.29B | 0.28B | 0.27B | 0.26B | 0.25B | 0.25B | 0.24B | 0.23B | 0.23B | 0.23B |
| Cash flow | ||||||||||
| Cash from operations | $4.5B | $4.1B | $4.4B | $5.2B | $6.5B | $7.3B | $6.5B | $7.7B | $9.1B | $10.6B |
| Depreciation and amortization | $826M | $813M | $803M | $763M | $789M | $870M | $826M | $722M | $715M | $680M |
| Stock-based compensation | $155M | $136M | $140M | $142M | $148M | $162M | $183M | $214M | $260M | $256M |
| Acquisitions | $0.0M | $439M | $4.0M | $0.0M | $0.0M | $38.0M | $4.0M | $0.0M | $382M | $0.0M |
| Share buybacks | $2.4B | $1.4B | $1.3B | $1.5B | $625M | $2.2B | $2.0B | $958M | $1.0B | $3.0B |
| Dividends paid | $757M | $785M | $814M | $844M | $861M | $869M | $875M | $908M | $951M | $979M |
| Dividends and buybacks | $3.2B | $2.2B | $2.1B | $2.3B | $1.5B | $3.0B | $2.9B | $1.9B | $2.0B | $4.0B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $5.2B | $5.2B | $4.4B | $5.4B | $6.2B | $4.6B | $4.3B | $5.8B | $5.5B | $6.6B |
| Total debt | $6.4B | $6.6B | $6.6B | $6.6B | $6.6B | $7.3B | $7.3B | $8.0B | $8.0B | $9.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $100.2B | $103.5B | $104.2B | $110.1B | $116.8B | $120.5B | $115.7B | $126.0B | $133.2B | $143.7B |
| Total liabilities | $77.0B | $79.8B | $81.3B | $84.2B | $87.6B | $91.6B | $94.2B | $101.1B | $105.3B | $110.8B |
| Shareholders' equity | $23.2B | $23.7B | $22.9B | $25.9B | $29.2B | $28.9B | $21.6B | $24.9B | $27.9B | $32.9B |
| Margins | ||||||||||
| EBITDA margin | 19.0% | 13.5% | 13.6% | 13.4% | 13.7% | 16.3% | 12.3% | 10.8% | 15.7% | 18.2% |
| Net margin | 10.9% | 7.1% | 8.3% | 8.3% | 8.4% | 10.5% | 7.7% | 7.2% | 10.8% | 12.9% |
| Returns | ||||||||||
| Return on capital | 13.3% | 9.4% | 11.3% | 11.2% | 10.5% | 12.9% | 11.2% | 12.9% | 18.5% | 20.1% |
| Return on equity | 12.9% | 8.8% | 10.8% | 10.7% | 9.8% | 12.6% | 11.3% | 12.9% | 18.9% | 20.7% |
| Return on assets | 3.0% | 2.0% | 2.4% | 2.5% | 2.4% | 3.1% | 2.4% | 2.5% | 3.9% | 4.5% |
| Growth | ||||||||||
| Revenue growth | 3.0% | 4.6% | 4.8% | 4.3% | 1.3% | 8.9% | 5.9% | 12.2% | 12.2% | 5.2% |
| Net income growth | β12.4% | β31.8% | 22.7% | 3.9% | 2.9% | 35.8% | β22.4% | 5.2% | 67.1% | 25.8% |
| EPS growth | β5.5% | β28.7% | 26.6% | 6.9% | 6.1% | 37.7% | β18.8% | 8.7% | 67.9% | 27.8% |
| Share count change | β7.3% | β4.3% | β3.2% | β2.8% | β2.9% | β1.5% | β4.4% | β3.1% | β0.5% | β1.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.2x | 0.3x | 0.5x | 0.3x | 0.1x | 0.5x | 0.7x | 0.5x | 0.4x | 0.3x |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.3x | 0.2x | 0.3x | 0.3x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 12.2x | 8.4x | 9.4x | 10.1x | 10.6x | 14.1x | 10.6x | 10.0x | 16.8x | 19.3x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.6% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.6% | 0.5% |
| Quality scores | ||||||||||
| Accruals ratio | β1.5% | β2.1% | β1.8% | β2.4% | β3.4% | β3.1% | β3.1% | β3.9% | β3.1% | β3.1% |
Source: SEC EDGAR XBRL filings (CIK 0000086312). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.